Liver News and Research

RSS

COX2 inhibitor lumiracoxib could be an effective treatment for osteoarthritis

The use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) is widespread to reduce the pain associated with osteoarthritis; however the sideeffects of these drugs can be severe, sometimes leading to gastro-intestinal ulcer complications which account for around 7000 US and 1000 UK deaths each year.

21 Aug 2004

Fruit and vegetables eaten before pregnancy lowers risk of leukemia

A new study led by researchers at the University of California, Berkeley, suggests that women who eat more vegetables, fruit and foods containing protein before pregnancy may have a lower risk of having a child who develops leukemia, the most common childhood cancer in the United States.

20 Aug 2004

Revised cholesterol-lowering guidelines constitute a major risk to public health

Recently revised cholesterol-lowering guidelines constitute a major risk to public health according to The International Network of Cholesterol Skeptics, a non-profit organization of doctors, scientists and researchers.

18 Aug 2004

Embryonic stem cell therapy show benefits in rebuilding damaged heart

Despite improvements in earlier diagnosis and treatment, cardiovascular disease is far and away the leading cause of death in the U.S. and the world.

18 Aug 2004

Paracentesis performed in an outpatient setting by gastrointestinal endoscopy assistants is safe

Large-volume paracentesis is a treatment used to remove excess fluid in the abdominal cavity resulting from such conditions as cirrhosis of the liver or cardiac failure. It is normally performed as an inpatient procedure due to possible complications, which may include infection, bleeding, and bowel perforation.

18 Aug 2004

Organ transplant recipients infected with West Nile virus develop more severe neurological illness

West Nile virus is an infection which in the last three years has had a significant impact in the United States. The virus is spread from birds to humans via mosquito bites. Symptoms include headache, fever and disorientation, and the disease can cause serious illness in a small percentage of infected people.

18 Aug 2004

New imaging technique may help cystic fibrosis sufferers

Now, Jefferson Lab scientists have used their expertise to build a small animal medical imager that's helping researchers develop a new gene therapy technique for cystic fibrosis.

15 Aug 2004

British team and NASA plan to take stem cells into space

The $US1 million project aims to explore ways to protect astronauts from space radiation in preparation for a manned mission to Mars in 2020.

12 Aug 2004

WHO tackles the parasitic disease Leishmaniasis in Afghanistan

A rapid intervention by the World Health Organization and its partners, the Massoud Foundation and HealthNet International, in Kabul, Afghanistan, made possible by a donation from the Belgian government, should dramatically reduce the incidence of leishmaniasis in less than two years.

10 Aug 2004

Binge drinking accounts for a substantial number of deaths each year in the United States

Binge drinking and harmful drinking, including both medium to high levels of regular alcohol consumption, account for a substantial number of deaths each year in the United States.

9 Aug 2004

Liver transplantation outcomes have significantly improved for patients with hepatitis B

Since the early 1990s, therapeutic options for patients undergoing liver transplantation for hepatitis B have evolved to include HBV immune globulin (HBIG) and lamivudine.

9 Aug 2004

Significant advance in the understanding of the hepatitis C virus (HCV)

Researchers have made a significant advance in the understanding of the hepatitis C virus (HCV) by identifying new genetic factors associated with clearing the virus spontaneously without the necessity for additional treatment.

9 Aug 2004

Correlation between HCV viral load and severity of liver disease

The significance of hepatitis C virus (HCV) serum titers (HCV viral load) has been examined in several clinical situations. There is much evidence that patients with a lower viral load have better response rates to anti-viral therapy compared to those with higher levels.

9 Aug 2004

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.

5 Aug 2004

PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures

A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.

5 Aug 2004

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

Brown University researchers have discovered that mefloquine, an anti-malarial drug, blocks two gap junction proteins, or connexins, in low doses and with very few side effects in the brains of laboratory mice.

5 Aug 2004

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics has announced the initiation of a multi-center, multi- national Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate in chronic hepatitis B (HBV) infected patients.

3 Aug 2004

Smart gene therapy might effectively prevent the organ damage commonly suffered by heart attack victims

Early intervention with a novel kind of "smart gene therapy" might effectively prevent the organ damage commonly suffered by heart attack victims, suggests a new animal study by researchers at Brigham and Women's Hospital in Boston and Duke University Medical Center.

2 Aug 2004

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.

2 Aug 2004

Scientists create mice that don't gain weight, even when fed fat-laden, high calorie diets

By altering the expression of a single -- albeit different – gene, Drs. Roger Davis (UMASS Medical School, USA) and Ying-Hue Lee (Academia Sinica, Taiwan) have succeeded in creating two different strains of transgenic mice that don't gain weight, even when fed fat-laden, high calorie diets.

2 Aug 2004

Liver News and Research

COX2 inhibitor lumiracoxib could be an effective treatment for osteoarthritis

Fruit and vegetables eaten before pregnancy lowers risk of leukemia

Revised cholesterol-lowering guidelines constitute a major risk to public health

Embryonic stem cell therapy show benefits in rebuilding damaged heart

Paracentesis performed in an outpatient setting by gastrointestinal endoscopy assistants is safe

Organ transplant recipients infected with West Nile virus develop more severe neurological illness

New imaging technique may help cystic fibrosis sufferers

British team and NASA plan to take stem cells into space

WHO tackles the parasitic disease Leishmaniasis in Afghanistan

Binge drinking accounts for a substantial number of deaths each year in the United States

Liver transplantation outcomes have significantly improved for patients with hepatitis B

Significant advance in the understanding of the hepatitis C virus (HCV)

Correlation between HCV viral load and severity of liver disease

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Smart gene therapy might effectively prevent the organ damage commonly suffered by heart attack victims

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Scientists create mice that don't gain weight, even when fed fat-laden, high calorie diets

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News